Mindfulness and Psychedelics: A Therapeutic Combination for Mental Health

Strategic Insights -

Recent research from University Hospital Psychiatry, University of Zurich, suggests a potential synergy between mindfulness practice and psychedelics in advancing clinical interventions for mental health. A double-blind, placebo-controlled study on 40 meditation practitioners found that a combination of meditation and an ayahuasca-inspired formulation containing DMT and harmine increased within- and between-network connectivity in the brain, while meditation alone reduced connectivity between networks. These findings have implications for improving emotional and psychological well-being, and further exploration of this synergistic potential in clinical contexts is warranted.

Key Takeaways:

  • The study investigated the effects of mindfulness practice and a psychedelic formulation on brain functional connectivity, with implications for advancing clinical interventions for mental health.
  • 40 meditation practitioners participated in a 3-day meditation retreat and were randomized to receive either placebo or buccal DMT-harmine (120 mg each).
  • The study found increased within- and between-network connectivity in the brain in the DMT-harmine group compared to the placebo group.
  • Meditation alone reduced connectivity between networks, while the combination of meditation and psychedelics increased within- and between-network connectivity.
  • The research suggests a return to typical brain organization shortly after the experience.
  • This study advances the understanding of how psychedelics and mindfulness practice shape brain function, offering insights into their complementary roles in emotional and psychological well-being.
  • Funders for this research include the BIAL Foundation, Reconnect Foundation, and a European Varela Award from Mind and Life Europe.
  • The study has been peer-reviewed and published in Imaging Neuroscience, 2025;3.

Statistics:

  • 40 meditation practitioners participated in the study.
  • 20 participants received placebo, while 20 received buccal DMT-harmine (120 mg each).
  • 3-day meditation retreat duration.
  • Increased within- and between-network connectivity in the brain was observed in the DMT-harmine group (120 mg each).
  • No evidence of prolonged cortical gradient disruption was observed in the DMT-harmine group.
  • The study's findings suggest a return to typical brain organization shortly after the experience.

Sources:

  • NewsRx. New Mental Health Diseases and Conditions Findings from University Hospital Psychiatry Discussed (Meditation, psychedelics, and brain connectivity: A randomized controlled resting-state fMRI study of N,N-dimethyltryptamine and harmine in a ...). Mental Health Weekly Digest. October 13, 2025; p 578.
  • Meditation, psychedelics, and brain connectivity: A randomized controlled resting-state fMRI study of N,N-dimethyltryptamine and harmine in a meditation retreat. Imaging Neuroscience, 2025;3.